Literature DB >> 4164554

Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus.

R H Alford, R D Rossen, W T Butler, J A Kasel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4164554

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  23 in total

1.  Respiratory and humoral immune response to aerosol and intramuscular pertussis vaccine.

Authors:  G Thomas
Journal:  J Hyg (Lond)       Date:  1975-04

2.  Clinical aspects of protective immunity of the respiratory tract.

Authors:  M Turner-Warwick
Journal:  Thorax       Date:  1975-12       Impact factor: 9.139

Review 3.  Immunity to viruses.

Authors:  D Isaacs
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791

4.  Nasal immunoglobulin responses in acute rubella determined by the immunofluorescent technique.

Authors:  J E Cradock-Watson; M K Ridehalgh; M S Bourne; E M Vandervelde
Journal:  J Hyg (Lond)       Date:  1973-09

5.  The mechanism of appearance of immunoglobulin A in nasal secretions in man.

Authors:  W T Butler; R D Rossen; T A Waldmann
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

6.  Immunoglobulins in external secretions.

Authors:  H C Goodman
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

7.  The response of ponies to Myxovirus influenzae A-equi 2. II. Immunoglobulin classes of antibody to the virus in serum and nasal secretions.

Authors:  B T Rouse; W J Ditchfield
Journal:  Can J Comp Med       Date:  1970-01

8.  Influenza--an evaluation of the current preventive measures.

Authors:  R B Hornick; Y Togo; A T Dawkins
Journal:  Trans Am Clin Climatol Assoc       Date:  1968

9.  A contribution of cellular immunity to protection against influenza in man.

Authors:  R Jennings; R J Fenton; M G McEntegart; C W Potter
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

10.  Class-specific antibodies to bovine respiratory syncytial virus in experimentally infected lambs.

Authors:  R Sharma; Z Woldehiwet
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.